IMPORTLA, LLC – Trademark Portfolio
Entity Type: 16
IMPORTLA, LLC owns a portfolio of 42 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as APEX, ENSO, ENVY, MAKO, and NANO. Of these, 21 are registered and 1 is pending. The portfolio spans 14 Nice Classification classes, led by Class 8 (Hand Tools) and Class 20 (Furniture). Headquartered in Orange, CA.
721 N. Eckhoff Street
Orange, CA 92868
Showing of trademarks Trademarks
Trademark Classifications
IMPORTLA, LLC's trademark portfolio spans 14 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does IMPORTLA, LLC have?
IMPORTLA, LLC has 42 U.S. trademarks filed with the USPTO. Of these, 21 registered, 1 pending, 5 abandoned, 15 cancelled.
What trademark classes does IMPORTLA, LLC file in?
IMPORTLA, LLC files trademarks across 14 Nice Classification classes. The most active classes are Class 8 (Hand Tools), Class 20 (Furniture), Class 35 (Advertising & Business), Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 8 covers hand tools and implements (hand-operated); cutlery; side arms; razors.
What are IMPORTLA, LLC's most well-known trademarks?
IMPORTLA, LLC's registered trademark portfolio includes well-known marks such as APEX, ENSO, ENVY, MAKO, and NANO. These are among 21 currently registered trademarks in the portfolio.
What is IMPORTLA, LLC's trademark registration success rate?
IMPORTLA, LLC has a 51% trademark registration rate, with 21 out of 41 resolved applications resulting in successful registration. Currently, 1 application is pending review.